EVE Health Group Limited Asset Resilience Ratio
EVE Health Group Limited asset resilience ratio. EVE Health Group Limited (EVE) has an Asset Resilience Ratio of 22.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EVE Health Group Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of EVE Health Group Limited (2011–2025)
Asset resilience ratio of EVE Health Group Limited from 2011 to 2025. This chart shows how EVE Health Group Limited's Asset Resilience Ratio has changed over time. Read EVE Health Group Limited total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down EVE Health Group Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EVE Health Group Limited (EVE) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$929.66K | 22.86% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$929.66K | 22.86% |
Asset Resilience Insights
- Good Liquidity Position: EVE Health Group Limited maintains a healthy 22.86% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EVE Health Group Limited Industry Peers by Asset Resilience Ratio
Compare EVE Health Group Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jde Peets Nv
AS:JDEP |
Packaged Foods | 0.03% |
|
COFCO Tunhe Sugar Co Ltd
SHG:600737 |
Packaged Foods | 0.08% |
|
CCL Products (India) Limited
NSE:CCL |
Packaged Foods | 0.05% |
|
Jiangxi Huangshanghuang Group Food Co Ltd
SHE:002695 |
Packaged Foods | 0.60% |
|
Sirio Pharma
SHE:300791 |
Packaged Foods | 0.01% |
|
Beingmate Baby & Child Food Co Ltd
SHE:002570 |
Packaged Foods | 4.39% |
|
Haoxiangni Jujube Co Ltd
SHE:002582 |
Packaged Foods | 6.50% |
|
Zhe Jiang Li Zi Yuan Food Co Ltd
SHG:605337 |
Packaged Foods | 6.20% |
EVE Health Group Limited Asset Resilience Ratio by Year (2011–2025)
EVE Health Group Limited asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for EVE Health Group Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 21.90% | AU$903.42K ≈ $639.23K |
AU$4.12 Million ≈ $2.92 Million |
+17.69pp |
| 2024-06-30 | 4.21% | AU$106.17K ≈ $75.12K |
AU$2.52 Million ≈ $1.79 Million |
-9.45pp |
| 2022-06-30 | 13.66% | AU$1.10 Million ≈ $780.03K |
AU$8.07 Million ≈ $5.71 Million |
-12.85pp |
| 2021-06-30 | 26.50% | AU$3.16 Million ≈ $2.24 Million |
AU$11.92 Million ≈ $8.44 Million |
-9.90pp |
| 2020-06-30 | 36.41% | AU$5.14 Million ≈ $3.64 Million |
AU$14.11 Million ≈ $9.99 Million |
+31.24pp |
| 2019-06-30 | 5.17% | AU$453.78K ≈ $321.08K |
AU$8.78 Million ≈ $6.21 Million |
-49.98pp |
| 2018-06-30 | 55.15% | AU$4.11 Million ≈ $2.91 Million |
AU$7.46 Million ≈ $5.28 Million |
+42.33pp |
| 2017-06-30 | 12.82% | AU$393.62K ≈ $278.51K |
AU$3.07 Million ≈ $2.17 Million |
+1.66pp |
| 2015-06-30 | 11.16% | AU$309.52K ≈ $219.01K |
AU$2.77 Million ≈ $1.96 Million |
+7.00pp |
| 2014-06-30 | 4.16% | AU$340.95K ≈ $241.25K |
AU$8.19 Million ≈ $5.79 Million |
+0.22pp |
| 2013-06-30 | 3.94% | AU$325.50K ≈ $230.31K |
AU$8.26 Million ≈ $5.84 Million |
+0.47pp |
| 2012-06-30 | 3.48% | AU$823.02K ≈ $582.34K |
AU$23.68 Million ≈ $16.76 Million |
-21.68pp |
| 2011-06-30 | 25.16% | AU$6.71 Million ≈ $4.75 Million |
AU$26.68 Million ≈ $18.88 Million |
-- |
About EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more